Alliance Foundation Trials reported that weekly electronic symptom monitoring improved quality of life for patients receiving treatment for advanced cancer. Published in JCO Oncology Practice, the trial found remote symptom tracking especially benefitted underserved groups, including Black patients and individuals with lower educational attainment. The results add to evidence that structured digital symptom workflows can reduce care friction and improve patient-reported outcomes, a factor that increasingly influences adoption in community oncology settings.